AIGH Capital Management as of June 30, 2022
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 46 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 36.5 | $139M | 820k | 169.36 | |
| DZS (DZSI) | 7.2 | $28M | 1.7M | 16.27 | |
| Adtran | 5.3 | $20M | 1.2M | 17.53 | |
| Aveo Pharmaceuticals Com New | 5.1 | $19M | 2.9M | 6.56 | |
| CyberOptics Corporation | 4.7 | $18M | 510k | 34.94 | |
| Transphorm (TGAN) | 3.7 | $14M | 3.8M | 3.72 | |
| Materion Corporation (MTRN) | 3.5 | $13M | 181k | 73.73 | |
| Sono Group (SEVCF) | 2.7 | $10M | 3.5M | 2.94 | |
| Aviat Networks Com New (AVNW) | 2.7 | $10M | 408k | 25.04 | |
| CalAmp | 2.6 | $9.7M | 2.3M | 4.17 | |
| Silicon Motion Technology Sponsored Adr (SIMO) | 2.5 | $9.6M | 114k | 83.70 | |
| Biosante Pharmaceuticals (ANIP) | 1.9 | $7.3M | 245k | 29.67 | |
| Everspin Technologies (MRAM) | 1.8 | $6.7M | 1.3M | 5.24 | |
| Theratechnologies | 1.7 | $6.6M | 2.9M | 2.27 | |
| Paratek Pharmaceuticals | 1.7 | $6.5M | 3.4M | 1.93 | |
| Scpharmaceuticals (SCPH) | 1.7 | $6.5M | 1.3M | 4.82 | |
| Airgain (AIRG) | 1.6 | $5.9M | 728k | 8.12 | |
| Icad Com New (ICAD) | 1.4 | $5.4M | 1.4M | 4.00 | |
| Scynexis Com New (SCYX) | 1.1 | $4.2M | 2.2M | 1.86 | |
| Bk Technologies Corporation | 1.0 | $3.6M | 1.4M | 2.65 | |
| Rf Inds Com Par $0.01 (RFIL) | 0.8 | $3.2M | 512k | 6.20 | |
| Medicenna Therapeutics Corp. (MDNAF) | 0.7 | $2.7M | 2.3M | 1.18 | |
| Ideal Pwr Com New (IPWR) | 0.7 | $2.6M | 213k | 12.23 | |
| Cognition Therapeutics (CGTX) | 0.7 | $2.5M | 911k | 2.78 | |
| Lightpath Technologies Com Cl A (LPTH) | 0.7 | $2.5M | 2.0M | 1.23 | |
| Saverone 2014 Sponsored Ads (SVRE) | 0.6 | $2.3M | 1.0M | 2.30 | |
| Vaccinex | 0.6 | $2.2M | 2.1M | 1.08 | |
| Ardelyx (ARDX) | 0.6 | $2.2M | 3.8M | 0.59 | |
| Tela Bio (TELA) | 0.6 | $2.1M | 307k | 7.01 | |
| Evolus (EOLS) | 0.5 | $2.0M | 173k | 11.60 | |
| Cellectar Biosciences Com Par | 0.5 | $1.9M | 1.8M | 1.04 | |
| Transcode Therapeutics | 0.4 | $1.6M | 1.3M | 1.26 | |
| Franklin Wireless Corporation (FKWL) | 0.3 | $1.3M | 390k | 3.23 | |
| Soleno Therapeutics Com New | 0.3 | $1.2M | 6.4M | 0.19 | |
| Neubase Therapeutics Ord | 0.3 | $1.1M | 1.0M | 1.05 | |
| Myomo Com New (MYO) | 0.3 | $1.0M | 617k | 1.68 | |
| Babcock & Wilcox Enterpr (BW) | 0.3 | $984k | 163k | 6.03 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $962k | 998k | 0.96 | |
| Processa Pharmaceuticals Com New | 0.2 | $853k | 304k | 2.81 | |
| Context Therapeutics (CNTX) | 0.2 | $742k | 1.2M | 0.62 | |
| Rezolute Com New (RZLT) | 0.1 | $273k | 85k | 3.22 | |
| Bridgeline Digital (BLIN) | 0.1 | $215k | 178k | 1.21 | |
| Cyclo Therapeutics *w Exp 11/14/202 Call Option (CYTHW) | 0.0 | $147k | 294k | 0.50 | |
| Rvl Pharmaceuticals SHS (RVLPQ) | 0.0 | $117k | 85k | 1.37 | |
| Nls Pharmaceutics *w Exp 09/25/202 Call Option (NLSPW) | 0.0 | $98k | 827k | 0.12 | |
| Parabellum Acquisition Corp *w Exp 99/99/999 Call Option | 0.0 | $38k | 589k | 0.06 |
